angiotensin ii, des-phe(8)- has been researched along with Chronic Lung Injury in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Gao, F; Liu, Z | 1 |
| Bertoldi, G; Calò, LA; Rigato, M | 1 |
| Moncada, S; Peiró, C | 1 |
| Chen, QF; Hao, H; Hu, QD; Huang, YH; Kuang, XD; Zhou, XY | 1 |
| de Visser, YP; de Vries, L; Fidder, M; Folkerts, G; Laghmani, el H; Rink, R; Roks, AJ; Sengers, RM; Wagenaar, GT; Walther, FJ | 1 |
| Hu, K; Kang, J; Li, Y; Lu, W; Tang, S; Xu, L; Yu, S; Zhou, X | 1 |
| Li, X; Molina-Molina, M; Piasecki, CC; Uhal, BD | 1 |
1 review(s) available for angiotensin ii, des-phe(8)- and Chronic Lung Injury
| Article | Year |
|---|---|
Angiotensin signalling in pulmonary fibrosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensins; Animals; Apoptosis; Cytoprotection; Humans; Lung Injury; MAP Kinase Kinase 4; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Respiratory Mucosa; Signal Transduction | 2012 |
6 other study(ies) available for angiotensin ii, des-phe(8)- and Chronic Lung Injury
| Article | Year |
|---|---|
Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Diminazene; Hyperoxia; Imidazoles; Leucine; Lung Injury; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A | 2019 |
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
Topics: Angiotensin I; Anti-Inflammatory Agents; Antioxidants; Bartter Syndrome; Gitelman Syndrome; Humans; Lung Injury; Peptide Fragments | 2020 |
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Lung; Lung Injury; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
Topics: Angiotensin I; Angiotensin II; Animals; Cytoprotection; Down-Regulation; Heptanoic Acids; Liver; Lung Injury; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Lipoxin; Renin-Angiotensin System; Up-Regulation | 2019 |
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
Topics: Angiotensin I; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Bronchoalveolar Lavage; Cell Proliferation; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Injury; Male; Oxygen; Peptide Fragments; Pneumonia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Angiotensin-(1-7) inhibits inflammation and oxidative stress to relieve lung injury induced by chronic intermittent hypoxia in rats.
Topics: Angiotensin I; Animals; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Hypoxia; Immunohistochemistry; Inflammation; Lung; Lung Injury; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Sleep Apnea, Obstructive; Vasodilator Agents | 2016 |